Breast Cancer and Depression

Celsias

 

UCLA researchers have received a $5 million grant from the National Cancer Institute for a study aimed at developing a risk profile for breast cancer survivors likely to suffer from depression. The prevalence of depression among survivors is three to five times greater than in the general population.
 
UCLA will be teaming on the five-year study with Kaiser Permanente, which will provide the 300 volunteers needed for the study by culling through electronic patient records to locate women who have been treated for breast cancer and have not had a history of depression.
 
breast cancer Researchers believe that cancer and its treatment induce inflammation, which in turn leads to sleep disturbance and depression. Sleep disturbance occurs in more than half of breast cancer survivors and is thought to contribute to the elevated risk of depression in these women. Depression negatively impacts quality of life and increases the risk of death, possibly due to an increased chance of cancer recurrence.
 
Through the study, researchers hope to find out if certain sub-sets of breast cancer survivors are at greater risk for depression by examining their DNA for potential biomarkers and genetic anomalies. If they can identify a risk profile, a study would be launched later to evaluate prevention measures, said the study's principal investigator, Dr. Michael Irwin, a professor of psychiatry and biobehavioral sciences at the Cousins Center for Psychoneuroimmunology, part of the Semel Institute for Neuroscience and Human Behavior at UCLA.
 
"Depression in breast cancer survivors is a huge problem. It often goes undiagnosed and isMichael Irwin undertreated," Irwin said. "If we can identify those breast cancer survivors at elevated risk for sleep disturbance and, therefore, depression, we can diagnose and treat it earlier, with better outcomes. Additionally, if we can identify those at greatest risk, efforts can be implemented early to prevent the occurrence of depression in the first place.
 
"Because depression is so prevalent and difficult to treat in breast cancer survivors, prevention of depression will dramatically improve the quality of their life."
 
For many cancer patients, their survival is complicated by long-term physical and behavioral late effects of their treatment, especially depression, Irwin said. Yet despite the high prevalence of depression among breast cancer survivors, the unique clinical, behavioral and biological factors that contribute to this increased depression risk is not known.
 
"There are no published prospective data that have examined the independent contribution of sleep disturbance on depression occurrence in breast cancer survivors," Irwin said. "Increasing evidence implicates that sleep disturbance is activating inflammatory signaling, which serves as a biological mechanism that contributes to depression. We hope to define the genomic and biologic processes that results in this depression."
 
Irwin's ultimate goal is preventing the cascade of events that lead to depression — inflammation and sleep disturbance — but more information is needed first.  This study is vital to providing valuable clues as to how that cascade occurs, he said.
 

 

Add a comment
  • to get your picture next to your comment (not a member yet?).
  • Posted on Nov. 20, 2012. Listed in:

    Pledge to do these related actions

    Get to know your local plant life for medicinal purposes, 92°

    Learn about (your) local plants, wild plants, for herbal/medicinal use. It's possible in a post ...

    Stop Using Xanthan Gum in Infant Formula, 11°

    It's reported that xanthan gum could cause necrotizing enterocolitis, or NEC in baby under 12 ...

    Food for Change: eat only plant-based foods for one whole WEEK, 116°

    What is it like to eat only plant-based foods for a whole week? If you ...

    Follow these related projects

    susan meadoiws

    New york, United States

    Leadership Rewired

    Online, Australia

    Featured Companies & Orgs